Skip to main content

Advertisement

SpringerLink
Log in

Auto-immune hepatitis in a patient with multiple sclerosis treated with alemtuzumab

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Coles AJ, Cohen JA, Fox EJ et al (2017) Alemtuzumab CARE-MS II 5 years follow-up: efficacy and safety findings. Neurology 89:1117–1126

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Muratori P, Fabbri A, Lalanne C, Lenzi M, Muratori L (2015) Autoimmune liver disease and concomitant extrahepatic autoimmune disease. Eur J Gastroenterol Hepatol 27:1175–1179

    Article  PubMed  CAS  Google Scholar 

  3. De Seze J, Canva Delcambre V, Fajardy I et al (2005) Autoimmune hepatitis and multiple sclerosis: a coincidental association? Mult Scler 11:691–693

    Article  PubMed  Google Scholar 

  4. Cação G, Santos E, Martins Silva A (2018) Concurrent autoimmune hepatitis in multiple sclerosis. Mult Scler 24(3):350–353

    Article  PubMed  Google Scholar 

  5. Hennes EM, Zeniya M, Czaja AJ et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176

    Article  PubMed  Google Scholar 

  6. Baker D, Herrod SS, Alvarez-Gonzalez C, Giovannoni G, Schmierer K (2017) Interpreting lymphocyte reconstitution data from the pivotal phase 3 trials of alemtuzumab. JAMA Neurol 74(8):961–969

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study has received no funding.

Author information

Authors and Affiliations

  1. Department of Neurology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200, Brussels, Belgium

    Souraya El Sankari & Vincent van Pesch

  2. Department of Hepato-GastroEnterology, Cliniques Universitaires Saint-Luc, Brussels, Belgium

    Géraldine Dahlqvist & Laurent Monino

Authors
  1. Souraya El Sankari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Géraldine Dahlqvist
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laurent Monino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vincent van Pesch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Souraya El Sankari.

Ethics declarations

Conflict of interest

Souraya ElSankari has received travel grants from Biogen, Bayer Schering, Sanofi Genzyme, Merck, and Teva. Her institution receives honoraria for consultancy and lectures from Biogen, Bayer Schering, Sanofi Genzyme, Merck, as well as research grants from Novartis Pharma, Roche and Bayer Schering. Géraldine Dahlqvist: reports no disclosures. Laurent Monino: reports no disclosures. Vincent van Pesch: has received travel grants from Biogen, Bayer Schering, Sanofi Genzyme, Merck, Teva, Novartis Pharma and Roche. His institution receives honoraria for consultancy and lectures from Biogen, Bayer Schering, Sanofi Genzyme, Merck, Roche, Teva and Novartis Pharma as well as research grants from Novartis Pharma, Roche and Bayer Schering.

Ethical approval

All procedures performed in this study were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendements.

Informed consent

Informed consent was obtained from the subject included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El Sankari, S., Dahlqvist, G., Monino, L. et al. Auto-immune hepatitis in a patient with multiple sclerosis treated with alemtuzumab. Acta Neurol Belg 118, 331–333 (2018). https://doi.org/10.1007/s13760-018-0922-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-018-0922-z

Search

Navigation